Literature DB >> 8175112

A nationwide survey of liver biopsy--is there a need to increase resources, manpower and training?

S Y Chuah1, G A Moody, A C Wicks, J F Mayberry.   

Abstract

A postal questionnaire survey was conducted to establish the pattern of current practice of liver biopsy, to estimate the frequency of adverse events and their possible associations, and to compare respondents' personal preferences with what they offer patients. Three hundred and sixty-four members of the British Society of Gastroenterology (BSG) were questioned. There were 296 returns, of which 278 were appropriate, giving an overall response rate of 81.3%. Over the previous 2 years complications were reported in 80 patients who required blood transfusion, 11 who needed laparotomy (including 1 for pain), 13 with septicemic shock, 29 who had peritonitis, and 1 with a subphrenic collection; 53 had pulmonary complications (hemoptysis, pneumothorax and 1 hemothorax), and there were 19 deaths. The overall complication rate was 5.6 per 1,000, and the mortality rate 5.2 per 10,000. The complication rate gradually decreased with increasing number of biopsies performed until the number reached 20 per month, after which there was a significant increase in complications (chi 2 = 42.98, p < 0.001). Although 50% of the respondents were themselves prepared to have a liver biopsy on a day case basis, only 11% do it routinely on patients, and 72% do not offer it at all (chi 2 = 76.8, p < 0.001). There were no differences in complication and death rates between the above groups, but those who do occasional (< 50%) day case biopsies have a significantly higher complication rate (chi 2 = 24.3, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8175112

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  The practice of percutaneous liver biopsy in a gastrohepatology day hospital: a retrospective study on 835 biopsies.

Authors:  Giovanni Clemente Actis; Alda Olivero; Marco Lagget; Rinaldo Pellicano; Antonina Smedile; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

2.  Sonographically guided puncture of the pancreas: incidence of complications, and risk factors.

Authors:  Michael Mueller; Richard Andrew Mason; Wolfgang Kratzer; Suemeyra Oeztuerk; Mark Martin Haenle
Journal:  J Med Ultrason (2001)       Date:  2012-07-04       Impact factor: 1.314

3.  Increased gall bladder volume in primary sclerosing cholangitis.

Authors:  P C van de Meeberg; P Portincasa; F H Wolfhagen; K J van Erpecum; G P VanBerge-Henegouwen
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

4.  Liver biopsy: blind or guided?

Authors:  G Vautier; B Scott; D Jenkins
Journal:  BMJ       Date:  1994-12-03

5.  Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience.

Authors:  V Takyar; O Etzion; T Heller; D E Kleiner; Y Rotman; M G Ghany; N Fryzek; V H Williams; E Rivera; S Auh; T J Liang; J H Hoofnagle; C Koh
Journal:  Aliment Pharmacol Ther       Date:  2017-01-10       Impact factor: 8.171

6.  Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsy.

Authors:  Patrick Chevallier; Frederic Ruitort; Alban Denys; Pascal Staccini; Marie Christine Saint-Paul; Denis Ouzan; Jean Paul Motamedi; Albert Tran; Pierre Schnyder; Jean Noël Bruneton
Journal:  Eur Radiol       Date:  2004-08-13       Impact factor: 5.315

7.  Emergency right hepatectomy after laparoscopic tru-cut liver biopsy.

Authors:  Nicolás Quezada; Felipe León; Jorge Martínez; Nicolás Jarufe; Juan Francisco Guerra
Journal:  Int J Surg Case Rep       Date:  2015-01-14

8.  Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years.

Authors:  Michael Mueller; Wolfgang Kratzer; Suemeyra Oeztuerk; Manfred Wilhelm; Richard Andrew Mason; Ren Mao; Mark Martin Haenle
Journal:  BMC Gastroenterol       Date:  2012-12-05       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.